About Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie
During the past decade, Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
2020-08-24
2027-12-30
Active, not recruiting
800
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie
According to Clinical.Site data, the most researched conditions in "Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie" are
"Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie
Most popular intervention types in "Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody" (1 trials), "Carboplatin" (1 trials), "Durvalumab" (1 trials) and "Nab-Paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie
The vast majority of trials in "Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie" are
2 trials for "All" genders.
Clinical Trials Status at Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie
Currently, there are NaN active trials in "Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".